Anhydrol Forte 20% w/v Cutaneous Solution

Land: Irland

Språk: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
22-09-2016

Aktiv ingrediens:

Aluminium chloride hexahydrate

Tilgjengelig fra:

Dermal Laboratories Ltd

ATC-kode:

D11AA

INN (International Name):

Aluminium chloride hexahydrate

Dosering :

20 percent weight/volume

Legemiddelform:

Cutaneous solution

Resept typen:

Product not subject to medical prescription

Terapeutisk område:

Antihidrotics

Autorisasjon status:

Marketed

Autorisasjon dato:

1982-03-15

Preparatomtale

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Anhydrol Forte 20% w/v Cutaneous Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Aluminium Chloride Hexahydrate 20.0 % w/v.
For full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cutaneous solution
Clear, colourless, evaporative solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the topical treatment of hyperhidrosis specifically involving
axillae, hands or feet.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For adults, children and the elderly.
Apply to the affected sites at night, as required, and allow to dry.
Wash off in the morning.
4.3 CONTRAINDICATIONS
Not to be used in cases of sensitivity to any of the ingredients.
Not to be used in axillae within 12 hours of using depilatories or
shaving.
Not to be used immediately after bathing.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Care should be taken to restrict the application to the affected sites
only.
Keep away from the eyes and mucous membranes.
Care should be taken to avoid Anhydrol Forte coming into direct
contact with clothing, polished surfaces, jewellery or
metal.
Replace cap tightly after use.
For external use only.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Do not bathe immediately before use and, if the axillae are treated,
do not shave or use depilatories on this area within 12
hours before or after use.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_7_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_
                                
                                read_full_document
                                
                            

Søk varsler relatert til dette produktet